Biotech Policy Group LLC
Anne Marie Finley is a regulatory and health care policy strategist. She is the President of Biotech Policy Group, a consulting firm she founded that focuses on development of products for rare diseases and unmet medical needs.
She has more than 20 years’ experience in senior policy positions at the US Food and Drug Administration, US Department of Health and Human Services, and the US Congress. She led the government relations and public policy teams at Celgene, GE Healthcare and Amersham Health.
Anne Marie is a graduate of Georgetown University and earned her MS in Science and Technology Commercialization at the University of Texas at Austin McCombs School of Business.
She was named a "Top 50 Global Thought Leader in Orphan Drugs and Rare Diseases" by the World Orphan Drug Congress.
Monday, September 23
10:30 AM – 12:00 PM
Tuesday, September 24
3:15 PM – 3:45 PM